Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
50.0%
% of PPH's 27 holdings also in FTXH
24.0%
% of FTXH's 51 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 6.6% | 6.9% | 6.6% |
|
MERCK & CO. INC. | 6.2% | 7.4% | 6.2% |
|
ABBVIE INC | 5.8% | 7.1% | 5.8% |
|
PFIZER INC | 4.5% | 7.3% | 4.5% |
|
BRISTOL-MYERS SQUIBB CO | 4.4% | 7.4% | 4.4% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to FTXH
 |
NOVO-NORDISK A/S-SPONS ADR | 9.5% |
|
ELI LILLY & CO | 8.4% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.2% |
 |
NOVARTIS AG-ADR | 4.8% |
|
AMERISOURCEBERGEN CORP | 4.7% |
|
MCKESSON CORP | 4.7% |
 |
SANOFI-AVENTIS-ADR | 4.5% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.4% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.2% |
 |
TEVA PHARMACEUTICAL-SP ADR | 2.9% |
PPH Underweight Relative to FTXH
|
AMGEN INC | -3.6% |
|
CARDINAL HEALTH INC | -3.6% |
|
REGENERON PHARMACEUTICALS | -3.6% |
|
VERTEX PHARMACEUTICALS INC | -3.5% |
|
GILEAD SCIENCES INC | -3.5% |
|
BIOGEN IDEC INC | -3.4% |
|
UNITED THERAPEUTICS CORP | -3.4% |
|
BRISTOL-MYERS SQUIBB CO | -3.0% |
|
PFIZER INC | -2.9% |
|
CHARLES RIVER LABORATORIES | -2.2% |